These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25587908)

  • 41. Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder.
    Molinaro M; Sacktor N; Nakigozi G; Anok A; Batte J; Kisakye A; Myanja R; Nakasujja N; Robertson KR; Gray RH; Wawer MJ; Saylor D
    J Acquir Immune Defic Syndr; 2020 Mar; 83(3):278-283. PubMed ID: 32032278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lower IQ and poorer cognitive profiles in treated perinatally HIV-infected children is irrespective of having a background of international adoption.
    Van den Hof M; Ter Haar AM; Scherpbier HJ; Reiss P; Wit FWNM; Oostrom KJ; Pajkrt D
    PLoS One; 2019; 14(12):e0224930. PubMed ID: 31805059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive impairment and antiretroviral treatment in a Peruvian population of patients with human immunodeficiency virus.
    Guevara-Silva EA
    Neurologia; 2014 May; 29(4):224-9. PubMed ID: 23972623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population.
    Ciccarelli N; Baldonero E; Milanini B; Fabbiani M; Cauda R; Di Giambenedetto S; Silveri MC
    Infez Med; 2019 Sep; 27(3):274-282. PubMed ID: 31545771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive Decline in Relation to Psychological Wellbeing and HIV Disease- and Treatment Characteristics in HIV-Infected Patients on cART: A One-Year Follow-Up Study.
    Janssen MAM; Koopmans PP; Kessels RPC
    AIDS Behav; 2017 Jun; 21(6):1728-1734. PubMed ID: 27752871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropsychological impairment and gender differences in HIV-1 infection.
    Faílde-Garrido JM; Alvarez MR; Simón-López MA
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):494-502. PubMed ID: 18950367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder.
    Gates TM; Cysique LA; Siefried KJ; Chaganti J; Moffat KJ; Brew BJ
    AIDS; 2016 Feb; 30(4):591-600. PubMed ID: 26825032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial.
    Boivin MJ; Barlow-Mosha L; Chernoff MC; Laughton B; Zimmer B; Joyce C; Bwakura-Dangarembizi M; Ratswana M; Abrahams N; Fairlie L; Gous H; Kamthunzi P; McCarthy K; Familiar-Lopez I; Jean-Phillippe P; Coetzee J; Violari A; Cotton MF; Palumbo PE;
    AIDS; 2018 Jan; 32(2):189-204. PubMed ID: 29112069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The HIV Dementia Scale: predictive power in mild dementia and HAART.
    Bottiggi KA; Chang JJ; Schmitt FA; Avison MJ; Mootoor Y; Nath A; Berger JR
    J Neurol Sci; 2007 Sep; 260(1-2):11-5. PubMed ID: 17482212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
    Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
    J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human immunodeficiency virus dementia patients in Africa: How many? Who cares? And where to from here?
    Birbeck GL
    J Neurovirol; 2005; 11 Suppl 3():30-3. PubMed ID: 16540452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Limitations of the International HIV Dementia Scale in the current era.
    Milanini B; Paul R; Bahemana E; Adamu Y; Kiweewa F; Langat R; Owuoth J; Allen E; Polyak C; Ake J; Valcour V;
    AIDS; 2018 Nov; 32(17):2477-2483. PubMed ID: 30134293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive reserve and neuropsychological functioning in older HIV-infected people.
    Milanini B; Ciccarelli N; Fabbiani M; Limiti S; Grima P; Rossetti B; Visconti E; Tamburrini E; Cauda R; Di Giambenedetto S
    J Neurovirol; 2016 Oct; 22(5):575-583. PubMed ID: 26965299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
    Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
    AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-associated cognitive disorders in perinatally infected children and adolescents: a novel composite cognitive domains score.
    Phillips NJ; Hoare J; Stein DJ; Myer L; Zar HJ; Thomas KGF
    AIDS Care; 2018; 30(sup1):8-16. PubMed ID: 29681168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microalbuminuria: a sentinel of neurocognitive impairment in HIV-infected individuals?
    Moulignier A; Viret-Vilayphon AC; Lescure FX; Plaisier E; Salomon L; Lamirel C; Pialoux G;
    J Neurol; 2020 May; 267(5):1368-1376. PubMed ID: 31980868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India.
    Gupta JD; Satishchandra P; Gopukumar K; Wilkie F; Waldrop-Valverde D; Ellis R; Ownby R; Subbakrishna DK; Desai A; Kamat A; Ravi V; Rao BS; Satish KS; Kumar M
    J Neurovirol; 2007 Jun; 13(3):195-202. PubMed ID: 17613709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Legacy effect on neuropsychological function in HIV-infected men on combination antiretroviral therapy.
    Qu Y; Weinstein A; Wang Z; Cheng Y; Kingsley L; Levine A; Martin E; Munro C; Ragin AB; Rubin LH; Sacktor NW; Seaberg EC; Becker JT;
    AIDS; 2022 Jan; 36(1):19-27. PubMed ID: 34524146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Montreal Cognitive Assessment-Basic (MoCA-B) is not a reliable screening tool for cognitive decline in HIV patients receiving combination antiretroviral therapy in rural South Africa.
    Hakkers CS; Beunders AJM; Ensing MHM; Barth RE; Boelema S; Devillé WLJ; Tempelman HA; Coutinho RA; Hoepelman AIM; Arends JE; van Zandvoort MJE
    Int J Infect Dis; 2018 Feb; 67():36-40. PubMed ID: 29183843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery.
    Cysique LA; Maruff P; Darby D; Brew BJ
    Arch Clin Neuropsychol; 2006 Feb; 21(2):185-94. PubMed ID: 16343841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.